Xanthomas;Xanthomes

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 1 I, 2003, Pages 65-68

  Naeyaert, J M ^a  

^a CHU   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOPROTEIN; CHOLESTEROL; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; FAMILIAL HYPERCHOLESTEROLEMIA; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HYPERLIPOPROTEINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIPOPROTEIN BLOOD LEVEL; NEUROFIBROMATOSIS; PLASMAPHERESIS; XANTHOMA; YAG LASER;

HUMANS; XANTHOMATOSIS;

EID: 0037222517     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Parker F. Normocholesterolemic xanthomatosis. Arch Dermatol 1986;122:1253-6.
2. e édition, 1999, Paris, Masson, pp. 530-2.
3. th edition, 1998, Oxford, Blackwell Sciences, pp. 2604-7.
4. Borelli C, Kaudewitz P. Xanthelasma palpebrarum: treatment with the erbium-YAG laser. Lasers Surg Med 2001;29:260-4.
5. Eeckhout I, Vogelaers D, Geerts ML, Naeyaert JM. Xanthomas due to generalized œdema. Br J Dermatol 1997;136:601-3.
6. Stockman A, Delanghe J, Geerts ML, Naeyaert JM. Diffuse plane normolipaemic xanthomatosis in a patient with chronic lymphatic leukaemia and monoclonal gammopathy. Dermatology 2002;204:351-4.
7. Text Atlas of histiocytic disorders. Caputo R, 1998, London, Martin Dunitz, pp. 1-145.
8. Bel S, Garcia-Patos V, Rodriguez L, Selva A, Diaz P, Wolthers BG et al. Cerebrotendinous xanthomatosis. J Am Acad Dermatol 2001;45:292-5